114 related articles for article (PubMed ID: 1551304)
21. Vortex keratopathy associated with atovaquone.
Shah GK; Cantrill HL; Holland EJ
Am J Ophthalmol; 1995 Nov; 120(5):669-71. PubMed ID: 7485371
[TBL] [Abstract][Full Text] [Related]
22. Atovaquone for Pneumocystis carinii pneumonia.
Stoeckle M; Tennenberg A
Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825772
[No Abstract] [Full Text] [Related]
23. Atovaquone for Pneumocystis carinii pneumonia.
Lederman MM; van der Horst C
Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825771
[No Abstract] [Full Text] [Related]
24. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P
J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851
[TBL] [Abstract][Full Text] [Related]
25. Overdose of atovaquone in a patient with AIDS.
Cheung TW
AIDS; 1999 Oct; 13(14):1984-5. PubMed ID: 10513663
[No Abstract] [Full Text] [Related]
26. Mepron for AIDS-related pneumonia.
Am Pharm; 1993 Mar; NS33(3):14-5. PubMed ID: 8475842
[No Abstract] [Full Text] [Related]
27. A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia.
Hughes WT
Ann Intern Med; 1992 Jun; 116(11):953-4. PubMed ID: 1580456
[No Abstract] [Full Text] [Related]
28. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
29. Rapid high-performance liquid chromatographic assay for atovaquone.
Hansson AG; Mitchell S; Jatlow P; Rainey PM
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):180-2. PubMed ID: 8634763
[TBL] [Abstract][Full Text] [Related]
30. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
[TBL] [Abstract][Full Text] [Related]
31. Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration.
Cotton D
AIDS Clin Care; 1995 Jul; 7(7):62. PubMed ID: 11362554
[TBL] [Abstract][Full Text] [Related]
32. Criteria for use of atovaquone oral suspension in adult inpatients and outpatients.
Goodwin SD; Fish DN
Am J Health Syst Pharm; 1995 Nov; 52(21):2460-2. PubMed ID: 8564614
[No Abstract] [Full Text] [Related]
33. Atovaquone suspension for treatment of Pneumocystis carinii pneumonia in HIV-infected patients.
Rosenberg DM; McCarthy W; Slavinsky J; Chan CK; Montaner J; Braun J; Dohn MN; Caldwell PT
AIDS; 2001 Jan; 15(2):211-4. PubMed ID: 11216929
[TBL] [Abstract][Full Text] [Related]
34. Atovaquone as prophylaxis against Pneumocystis carinii pneumonia.
Fisher MJ; Gazzard BG; Hawkins DA; Nelson MR
J Infect; 1994 Jan; 28(1):103-4. PubMed ID: 8163822
[No Abstract] [Full Text] [Related]
35. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.
Hughes WT; LaFon SW; Scott JD; Masur H
J Infect Dis; 1995 May; 171(5):1295-301. PubMed ID: 7751706
[TBL] [Abstract][Full Text] [Related]
36. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure.
Walker DJ; Wakefield AE; Dohn MN; Miller RF; Baughman RP; Hossler PA; Bartlett MS; Smith JW; Kazanjian P; Meshnick SR
J Infect Dis; 1998 Dec; 178(6):1767-75. PubMed ID: 9815231
[TBL] [Abstract][Full Text] [Related]
37. 566C80, an antimalarial hydroxynaphthoquinone with broad spectrum: experimental activity against opportunistic parasitic infections of AIDS patients.
Gutteridge WE
J Protozool; 1991; 38(6):141S-143S. PubMed ID: 1818143
[TBL] [Abstract][Full Text] [Related]
38. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia.
Warren E; George S; You J; Kazanjian P
Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Deresinski SC
Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
[TBL] [Abstract][Full Text] [Related]
40. Failure of low-dose atovaquone prophylaxis against Pneumocystis jiroveci infection in transplant recipients.
Rodriguez M; Sifri CD; Fishman JA
Clin Infect Dis; 2004 Apr; 38(8):e76-8. PubMed ID: 15095235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
